0

L-Dopa-(phenyl-d3)

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP53587294
CAS53587-29-4
Structure
MDL NumberMFCD00075014
Molecular Weight200.21
InChI KeyWTDRDQBEARUVNC-UOCCHMHCSA-N
Description≥98 atom % D, ≥98% (CP)
Assay≥98% (CP)
Linear Formula(HO)2C6D3CH2CH(NH2)CO2H
MP292 °C (dec.) (lit.)
Size250MG, 1G
Storage Conditions2-8°C
1

Expanding the Repertoire of L-DOPA's Actions: A Comprehensive Review of Its Functional Neurochemistry

Philippe De Deurwaerdère, Giuseppe Di Giovanni, Mark J Millan

Prog Neurobiol. 2017 Apr;151:57-100.

PMID: 27389773

1

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease

Yoshio Goshima, Daiki Masukawa, Yuka Kasahara, Tatsuo Hashimoto, Aderemi Caleb Aladeokin

Front Pharmacol. 2019 Oct 3;10:1119.

PMID: 31632270

1

Process Development for Efficient Biosynthesis of L-DOPA With Recombinant Escherichia Coli Harboring Tyrosine Phenol Lyase From Fusobacterium Nucleatum

Xiao-Ling Tang, Xiao Liu, Hui Suo, Zhi-Chao Wang, Ren-Chao Zheng, Yu-Guo Zheng

Bioprocess Biosyst Eng. 2018 Sep;41(9):1347-1354.

PMID: 29869726

1

Striatal Norepinephrine Efflux in l-DOPA-induced Dyskinesia

Corinne Y Ostock, Nirmal Bhide, Adam A Goldenberg, Jessica A George, Christopher Bishop

Neurochem Int. 2018 Mar;114:85-98.

PMID: 29371053

1

Synaptic Plasticity May Underlie l-DOPA Induced Dyskinesia

Anders Borgkvist, Ori J Lieberman, David Sulzer

Curr Opin Neurobiol. 2018 Feb;48:71-78.

PMID: 29125979

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode